Stocks
Stock Market News & Analysis
Latest stock picks, earnings reports, IPOs, and equity market analysis for investors.
Stocks
GSK's $10.6B Nuvalent Deal Fails to Rally Stock as Investors Eye Regulatory Hurdles
GSK shares dropped 3% after announcing a $10.6B Nuvalent takeover. The deal strengthens its lung cancer pipeline but inv
Stocks
SpaceX IPO Oversubscribed 2x Ahead of June 11 Pricing: Valuation Debate Intensifies
SpaceX's IPO is oversubscribed 2x with $150B in orders, but valuation concerns persist as Morningstar estimates fair val
Stocks
SpaceX IPO Fuels Global Rally; Asian Proxy Stocks Surge as Direct Access Limited
SpaceX's upcoming IPO, targeting a $1.8 trillion valuation, has ignited a global rally. Asian investors, facing access r
Stocks
Samsung Rebounds 5% After Circuit Breaker Crash: Is This the Buy of the Year?
Samsung shares rebounded 5% on Tuesday after a historic 10.2% plunge triggered South Korea's KOSPI circuit breaker. The
Stocks
Perplexity CEO Reaffirms 2028 IPO Timeline Amid Anthropic, OpenAI Filing Wave
Perplexity CEO Aravind Srinivas reaffirms the AI search startup's 2028 IPO timeline, even as Anthropic and OpenAI move c
Stocks
Foreign Capital Exodus from South Korea: Why Long-Term Investors Should Buy the Dip
Foreign investors have pulled $62 billion from South Korean stocks, but the selloff is driven by forced rebalancing, not
Stocks
Tango Therapeutics Stock Surges 51% on 92% Response Rate in Pancreatic Cancer Trial
Tango Therapeutics stock surged over 51% on Monday after early-stage trial data showed a 92% objective response rate for
Stocks
Inno Holdings Stock Surges 20x on AI Deal, But Fundamentals Signal Imminent Crash
Inno Holdings stock surged nearly 20x on a $3M AI deal, but the contract equals its market cap, no revenue is generated,
Stocks
Duolingo Stock Jumps 8% as Tech Recovery, Strong User Growth Offset AI Fears
Duolingo stock soared more than 8% Monday as investors returned to growth tech names, with the company reporting 27% rev
Stocks
Eli Lilly Stock Surges 4% as Retatrutide Data Strengthens Obesity Drug Pipeline
Eli Lilly shares climbed 4% on Monday after retatrutide data showed 19% weight loss at a 4 mg dose, bolstering its obesi
Stocks
ABAT Stock Surges 35% on DOE Grant Reinstatement: Why Selling Into Strength Makes Sense
ABAT stock surges 35% after DOE reinstates a $115M grant for its Tonopah Flats lithium project. However, deep losses, hi
Stocks
Marvell Technology Faces Potential Pullback Despite S&P 500 Inclusion Boost
Marvell Technology stock jumped on S&P 500 inclusion, but historical precedents, extreme valuation, and technical indica